Have a personal or library account? Click to login
Knockdown of Annexin A1 induces apoptosis, causing G2/M arrest and facilitating phagocytosis activity in human leukemia cell lines Cover

Knockdown of Annexin A1 induces apoptosis, causing G2/M arrest and facilitating phagocytosis activity in human leukemia cell lines

Open Access
|Aug 2021

References

  1. 1. R. Belvedere, V. Bizzarro, A. Popolo, F. Dal Piaz, M. Vasaturo, P. Picardi, L. Parente and A. Petrella, Role of intracellular and extracellular annexin A1 in migration and invasion of human pancreatic carcinoma cells, BMC cancer 14 (2014) 961–975; https://doi.org/10.1186/1471-2407-14-96110.1186/1471-2407-14-961
  2. 2. A. Sabran, E. Kumolosasi and I. Jantan, Effects of annexin A1 on apoptosis and cell cycle arrest in human leukemic cell lines, Acta Pharm. 69 (2019) 75–86; http://doi.org/10.2478/acph-2019-000510.2478/acph-2019-0005
  3. 3. E. Solito, C. De Coupade, S. Canaider, N. J. Goulding and M. Perretti, Transfection of annexin 1 in monocytic cells produces a high degree of spontaneous and stimulated apoptosis associated with caspase-3 activation, Br. J. Pharmacol. 133 (2001) 217–228; https://doi.org/10.1038/sj.bjp.070405410.1038/sj.bjp.0704054
  4. 4. C. W. D’Acunto, B. Fontanella, M. Rodriquez, M. Taddei, L. Parente and A. Petrella, Histone deacetylase inhibitor FR235222 sensitizes human prostate adenocarcinoma cells to apoptosis through up-regulation of Annexin A1, Cancer Lett. 295 (2010) 85–91; https://doi.org/10.1016/j.canlet.2010.02.01610.1016/j.canlet.2010.02.016
  5. 5. R. Debret, H. El Btaouri, L. Duca, I. Rahman, S. Radke, B. Haye, J. M. Sallenave and F. Antonicelli, Annexin A1 processing is associated with caspase-dependent apoptosis in BZR cells, FEBS Lett. 546 (2003) 195–202; https://doi.org/10.1016/s0014-5793(03)00570-210.1016/S0014-5793(03)00570-2
  6. 6. Y. Feng, J. Wu, X. Feng, D. Tao, J. Hu, J. Qin, X. Li, W. Xiao, K. Gardner, S. I. V. Judge, Q. Q. Li and J. Gong, Timing of apoptosis onset depends on cell cycle progression in peripheral blood lymphocytes and lymphocytic leukemia cells, Oncol. Rep. 17 (2007) 1437–1444; https://doi.org/10.3892/ or.17.6.1437
  7. 7. S. Fulda and K. M. Debatin, Extrinsic versus intrinsic apoptosis pathways in anticancer chemo-therapy, Oncogene 25 (2006) 4798–4811; https://doi.org/10.1038/sj.onc.120960810.1038/sj.onc.120960816892092
  8. 8. S. Inoue, G. Browne, G. Melino and G. M. Cohen, Ordering of caspases in cells undergoing apoptosis by the intrinsic pathway, Cell Death Differ. 16 (2009) 1053–1061; https://doi.org/10.1038/cdd.2009.2910.1038/cdd.2009.2919325570
  9. 9. E. Tothova, M. Fricova, N. Stecova, A. Kafkova and A. Elbertova, High expression of Bcl-2 protein in acute myeloid leukemia cells is associated with poor response to chemotherapy, Neoplasma 49 (2002) 141–144; https://pubmed.ncbi.nlm.nih.gov/12097997
  10. 10. A. Petrella, C. W. D’Acunto, M. Rodriquez, M. Festa, A. Tosco, I. Bruno, S. Terracciano, M. Taddei, L. G. Paloma and L. Parente, Effects of FR235222, a novel HDAC inhibitor, in proliferation and apoptosis of human leukaemia cell lines: role of annexin A1, Eur. J. Cancer 44 (2008) 740–749; https://doi.org/10.1016/j.ejca.2008.01.02310.1016/j.ejca.2008.01.02318295477
  11. 11. D. M. Patel, S. F. Ahmad, D. G. Weiss, V. Gerke and S. A. Kuznetsov, Annexin A1 is a new functional linker between actin filaments and phagosomes during phagocytosis, J. Cell Sci. 124 (2011) 578–588; https://doi.org/10.1242/jcs.07620810.1242/jcs.07620821245195
  12. 12. Z. Chen, E. Yoshihara, A. Son, Y. Matsuo, H. Masutani, K. Sugie, M. Maeda and J. Yodoi, Differential roles of Annexin A1 (ANXA1/lipocortin-1/lipomodulin) and thioredoxin binding protein-2 (TBP-2/VDUP1/TXNIP) in glucocorticoid signaling of HTLV-I-transformed T cells, Immunol. Lett. 13 (2010) 11–18; https://doi.org/10.1016/j.imlet.2010.04.00310.1016/j.imlet.2010.04.00320398702
  13. 13. Y. L. Wu, X. R. Jiang, D. M. Lillington, A. C. Newland and S. M. Kelsey, Upregulation of lipocortin 1 inhibits tumour necrosis factor-induced apoptosis in human leukaemic cells: a possible mechanism of resistance to immune surveillance, Br. J. Haematol. 111 (2000) 807–816; https://onlinelibrary.wiley.com/doi/pdf/10.1111/j.1365-2141.2000.02397.x10.1046/j.1365-2141.2000.02397.x
  14. 14. C. Jia, D. Kong, Y. Guo, L. Li and L. Quan, Enhanced antitumor effect of combination of annexin A1 knockdown and bortezomib treatment in multiple myeloma in vitro and in vivo, Biochem. Biophis. Res. Commun. 505 (2018) 720–725; https://doi.org/10.1016/j.bbrc.2018.09.14010.1016/j.bbrc.2018.09.14030292410
  15. 15. E. Uribe-Querol and C. Rosales, Control of phagocytosis by microbial pathogens, Front. Immunol. 8 (2017) 1–23; https://doi.org/10.3389/fimmu.2017.0136810.3389/fimmu.2017.01368566070929114249
  16. 16. J. Feng, X. Wang, H. Li, L. Wang and Z. Tang, Silencing of Annexin A1 suppressed the apoptosis and inflammatory response of preeclampsia rat trophoblasts, Int. J. Mol. Med. 42 (2018) 3125–3134; https://doi.org/10.3892/ijmm.2018.388710.3892/ijmm.2018.3887620208130272262
  17. 17. D. R. Green, Apoptotic pathways: Ten minutes to dead, Cell. 121 (2005) 671–674; https://doi.org/10.1016/j.cell.2005.05.01910.1016/j.cell.2005.05.01915935754
  18. 18. V. D. Moore and A. Letai, Rational design of therapeutics targeting the BCL-2 family: are some cancer cells primed for death but waiting for a final push? Adv. Exp. Med. Biol. 615 (2008) 159–175; https://doi.org/10.1007/978-1-4020-6554-5_810.1007/978-1-4020-6554-5_818437895
  19. 19. L. Franchi, T. Eigenbrod, R. Muñoz-Planillo and G. Nuñez, The inflammasome: a caspase-1-activation platform that regulates immune responses and disease pathogenesis, Nature Immunol. 10 (2009) 241–247; https://www.nature.com/articles/ni.1703
  20. 20. N. Vergnolle, P. Pagès, R. Guimbaud, S. Chaussade, L. Buéno, J. Escourrou and C. Comera, Annexin 1 is secreted in situ during ulcerative colitis in humans, Inflamm. Bowel Dis. 10 (2004) 584–592; https://doi.org/10.1097/00054725-200409000-0001310.1097/00054725-200409000-0001315472519
  21. 21. A. Denes, G. Lopez-Castejon and D. Brough, Caspase-1: is IL-1 just the tip of the ICEberg? Cell Death Dis. 3 (2012) e338-e346; https://doi.org/10.1038/cddis.2012.8610.1038/cddis.2012.86340658522764097
  22. 22. Q. H. Liu, M. L. Shi, J. Bai and J. N. Zheng, Identification of ANXA1 as a lymphatic metastasis and poor prognostic factor in pancreatic ductal adenocarcinoma, Asian Pac. J. Cancer Prev. 16 (2015) 2719–2724; https://doi.org/10.7314/apjcp.2015.16.7.271910.7314/APJCP.2015.16.7.2719
  23. 23. G. Li, S. He, L. Chang, H. Lu, H. Zhang, H. Zhang and J. Chiu, GADD45α and annexin A1 are involved in the apoptosis of HL-60 induced by resveratrol, Phytomedicine 18 (2011) 704–709; https://doi.org/10.1016/j.phymed.2010.11.01510.1016/j.phymed.2010.11.01521277758
  24. 24. S. Y. Park and I. S. Kim, Engulfment signals and the phagocytic machinery for apoptotic cell clearance, Exp. Mol. Med. 49 (2017) e331-e340; https://doi.org/10.1038/emm.2017.5210.1038/emm.2017.52545444628496201
  25. 25. I. K. H. Poon, C. D. Lucas, A. G. Rossi and K. S. Ravichandran, Apoptotic cell clearance: basic biology and therapeutic potential, Nat. Rev. Immunol. 14 (2014) 166–180; https://doi.org/10.1038/nri360710.1038/nri3607404026024481336
DOI: https://doi.org/10.2478/acph-2022-0005 | Journal eISSN: 1846-9558 | Journal ISSN: 1330-0075
Language: English
Page range: 109 - 122
Accepted on: Jan 23, 2021
Published on: Aug 30, 2021
Published by: Croatian Pharmaceutical Society
In partnership with: Paradigm Publishing Services
Publication frequency: 4 issues per year
Related subjects:

© 2021 Masyitah Hasan, Endang Kumolosasi, Ibrahim Jantan, Malina Jasamai, Norlaili Nazarudin, published by Croatian Pharmaceutical Society
This work is licensed under the Creative Commons Attribution-NonCommercial-NoDerivatives 4.0 License.